Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Freeman

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Journal of the American College of Cardiology|May 5, 2022
Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial FibrillationJames V Freeman, Angela Y Higgins, Yongfei Wang, et al.
JAMA Cardiology|July 4, 2019
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial FibrillationSean D Pokorney, DaJuanicia N Holmes, Laine Thomas, et al.
Heart (British Cardiac Society)|June 8, 2018
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillationMichael T Durheim, DaJuanicia N Holmes, Rosalia G Blanco, et al.
Circulation. Arrhythmia and Electrophysiology|November 17, 2017
Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation)Adam S Barnett, Sunghee Kim, Gregg C Fonarow, et al.
Medical Devices (Auckland, N.Z.)|September 2, 2017
Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillatorsJoseph S Ross, Jonathan Bates, Craig S Parzynski, et al.
The American Journal of Cardiology|February 4, 2021
Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)Manan Pareek, Avinainder Singh, Lina Vadlamani, et al.
Circulation. Arrhythmia and Electrophysiology|April 17, 2020
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AFBenjamin A Steinberg, DaJuanicia N Holmes, Karen Pieper, et al.
The American Journal of Cardiology|August 23, 2020
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)Malini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Circulation. Arrhythmia and Electrophysiology|December 14, 2019
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial FibrillationJames V Freeman, Peter Shrader, Karen S Pieper, et al.
Heart (British Cardiac Society)|August 10, 2017
Disease understanding in patients newly diagnosed with atrial fibrillationBrystana G Kaufman, Sunghee Kim, Karen Pieper, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|May 5, 2022
Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial FibrillationJames V Freeman, Angela Y Higgins, Yongfei Wang, et al.
JAMA Cardiology|July 4, 2019
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial FibrillationSean D Pokorney, DaJuanicia N Holmes, Laine Thomas, et al.
Heart (British Cardiac Society)|June 8, 2018
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillationMichael T Durheim, DaJuanicia N Holmes, Rosalia G Blanco, et al.
Circulation. Arrhythmia and Electrophysiology|November 17, 2017
Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation)Adam S Barnett, Sunghee Kim, Gregg C Fonarow, et al.
Medical Devices (Auckland, N.Z.)|September 2, 2017
Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillatorsJoseph S Ross, Jonathan Bates, Craig S Parzynski, et al.
The American Journal of Cardiology|February 4, 2021
Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)Manan Pareek, Avinainder Singh, Lina Vadlamani, et al.
Circulation. Arrhythmia and Electrophysiology|April 17, 2020
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AFBenjamin A Steinberg, DaJuanicia N Holmes, Karen Pieper, et al.
The American Journal of Cardiology|August 23, 2020
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)Malini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Circulation. Arrhythmia and Electrophysiology|December 14, 2019
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial FibrillationJames V Freeman, Peter Shrader, Karen S Pieper, et al.
Heart (British Cardiac Society)|August 10, 2017
Disease understanding in patients newly diagnosed with atrial fibrillationBrystana G Kaufman, Sunghee Kim, Karen Pieper, et al.
Pageof 27